D961H capsule 10mg

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Anastomotic Ulcer (AU)Duodenal UlcerDuodenal Ulcer (DU)Gastric UlcerGastric Ulcer (GU)Non-erosive Reflux Esophagitis Disease (NERD)Reflux EsophagitisReflux Esophagitis (RE)

Phase 3

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

CompletedNCT02153398

AstraZenecaAnastomotic Ulcer (AU), Duodenal Ulcer (DU), Gastric Ulcer (GU) +3

Start: 2014-06-30End: 2016-04-30Updated: 2017-01-19

A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

CompletedNCT03553563

AstraZenecaDuodenal Ulcer, Gastric Ulcer, Reflux Esophagitis

Start: 2018-07-24End: 2022-12-27Updated: 2026-03-04

Related Papers

Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1-14 Years with Chronic Gastric Acid-Related Disease.

2024-09-09